ELIZABETH SHPALL to Cell Separation
This is a "connection" page, showing publications ELIZABETH SHPALL has written about Cell Separation.
Connection Strength
2.044
-
Comparison of two methodologies for the enrichment of mononuclear cells from thawed cord blood products: The automated Sepax system versus the manual Ficoll method. Cytotherapy. 2017 Mar; 19(3):433-439.
Score: 0.487
-
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts. Bone Marrow Transplant. 2006 Mar; 37(6):575-82.
Score: 0.230
-
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma. Br J Haematol. 2017 05; 177(3):457-466.
Score: 0.123
-
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy. Cytotherapy. 2016 10; 18(10):1312-24.
Score: 0.118
-
Mobilization and selection of CD34-positive hematopoietic progenitors. Blood Rev. 1996 Mar; 10(1):1-7.
Score: 0.115
-
Stem cell isolation. Curr Opin Hematol. 1995 Nov; 2(6):452-9.
Score: 0.112
-
Isolation of CD34-positive hematopoietic progenitor cells. Immunomethods. 1994 Dec; 5(3):197-203.
Score: 0.105
-
Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myeloma. Cancer Res. 2011 Jul 15; 71(14):5040-9.
Score: 0.083
-
Mesenchymal stem cells in ex vivo cord blood expansion. Best Pract Res Clin Haematol. 2011 Mar; 24(1):83-92.
Score: 0.081
-
Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. Bone Marrow Transplant. 1991 Feb; 7(2):145-51.
Score: 0.081
-
CD3(+) and/or CD14(+) depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34(+) cell yields. Bone Marrow Transplant. 2010 Jun; 45(6):1000-7.
Score: 0.074
-
Ex-vivo purging of hematopoietic progenitor cells. Curr Hematol Rep. 2004 Jul; 3(4):257-64.
Score: 0.051
-
High-dose chemotherapy for breast cancer. Cancer Treat Res. 2000; 103:77-114.
Score: 0.037
-
Status of high-dose chemotherapy for breast cancer: a review. Biol Blood Marrow Transplant. 2000; 6(5):476-95.
Score: 0.037
-
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood. 1997 Dec 01; 90(11):4313-20.
Score: 0.032
-
Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipients. Cytotherapy. 2017 02; 19(2):272-284.
Score: 0.030
-
Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Blood. 1996 Jan 15; 87(2):456-64.
Score: 0.028
-
Transplantation of CD34+ hematopoietic progenitor cells. Cancer Invest. 1996; 14(6):589-96.
Score: 0.028
-
Transplantation of CD34+ hematopoietic progenitor cells. J Hematother. 1994; 3(2):145-7.
Score: 0.025
-
Positive selection of CD34+ hematopoietic progenitor cells for transplantation. Stem Cells. 1993 Oct; 11 Suppl 3:48-9.
Score: 0.024
-
Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment. Blood. 2013 Jul 18; 122(3):357-66.
Score: 0.024
-
Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell. J Hematother. 1992; 1(1):45-54.
Score: 0.022
-
Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres. Cancer. 1991 Sep 15; 68(6):1272-8.
Score: 0.021
-
Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One. 2011; 6(9):e22949.
Score: 0.021
-
Elimination of malignant clonogenic breast cancer cells from human bone marrow. Cancer Res. 1989 Aug 15; 49(16):4659-64.
Score: 0.018
-
Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):413-8.
Score: 0.011
-
Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol. 2000 Oct; 28(10):1181-6.
Score: 0.010
-
Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia. Biol Blood Marrow Transplant. 1999; 5(6):394-9.
Score: 0.009
-
Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology. Am J Clin Pathol. 1990 Jul; 94(1):8-13.
Score: 0.005